U.S. markets open in 3 hours 45 minutes
  • S&P Futures

    3,636.25
    +9.00 (+0.25%)
     
  • Dow Futures

    29,913.00
    +85.00 (+0.28%)
     
  • Nasdaq Futures

    12,198.25
    +46.00 (+0.38%)
     
  • Russell 2000 Futures

    1,844.10
    -0.50 (-0.03%)
     
  • Crude Oil

    45.08
    -0.63 (-1.38%)
     
  • Gold

    1,813.10
    +1.90 (+0.10%)
     
  • Silver

    23.38
    -0.07 (-0.30%)
     
  • EUR/USD

    1.1929
    +0.0016 (+0.13%)
     
  • 10-Yr Bond

    0.8780
    -0.0040 (-0.45%)
     
  • Vix

    21.31
    -0.33 (-1.52%)
     
  • GBP/USD

    1.3370
    +0.0014 (+0.10%)
     
  • USD/JPY

    103.9690
    -0.2810 (-0.27%)
     
  • BTC-USD

    17,159.85
    -6.80 (-0.04%)
     
  • CMC Crypto 200

    335.23
    -35.28 (-9.52%)
     
  • FTSE 100

    6,324.88
    -38.05 (-0.60%)
     
  • Nikkei 225

    26,644.71
    +107.40 (+0.40%)
     

Arrowhead Pharmaceuticals Inc (ARWR) CFO Kenneth Allen Myszkowski Sold $3 million of Shares

GuruFocus.com
·1 min read

- By insider

CFO of Arrowhead Pharmaceuticals Inc (30-Year Financial, Insider Trades) Kenneth Allen Myszkowski (insider trades) sold 43,505 shares of ARWR on 11/09/2020 at an average price of $69.37 a share. The total sale was $3 million.


Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by the overproduction of one or more proteins. Arrowhead Pharmaceuticals Inc has a market cap of $7.08 billion; its shares were traded at around $69.23 with and P/S ratio of 56.20. GuruFocus has detected 2 severe warning signs with Arrowhead Pharmaceuticals Inc. .

CEO Recent Trades:

  • CEO Christopher Richard Anzalone sold 100,000 shares of ARWR stock on 10/23/2020 at the average price of $58.21. The price of the stock has increased by 18.93% since.

CFO Recent Trades:

  • CFO Kenneth Allen Myszkowski sold 43,505 shares of ARWR stock on 11/09/2020 at the average price of $69.37. The price of the stock has decreased by 0.2% since.

  • CFO Kenneth Allen Myszkowski sold 29,166 shares of ARWR stock on 10/20/2020 at the average price of $54.04. The price of the stock has increased by 28.11% since.

For the complete insider trading history of ARWR, click here

.This article first appeared on GuruFocus.